Bleakley Financial Group, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1936953
PARSIPPANY, NJ
Position in VRTX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$9,139,832
+$1,447,734 QoQ
Shares Held
18,400
+6.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#385
of 1,742 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bleakley Financial Group, LLC holds $23,738,174 across 21 Biotechnology names. VRTX ranks #1 (38.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
18,400 | $9,139,832 | |
| 2 | ANAB |
Anaptysbio, Inc
|
42,761 | $2,886,367 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
12,538 | $1,536,908 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
14,793 | $1,172,936 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
129,381 | $1,132,730 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
11,638 | $1,011,924 | |
| 7 | BCAX |
Bicara Therapeutics Inc.
|
29,181 | $866,383 | |
| 8 | RPRX |
Royalty Pharma plc
|
14,626 | $820,079 |
All Filings in VRTX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,139,832 | 18,400 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $7,692,098 | 17,226 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $7,069,695 | 15,594 | Shares | Sole | 2026-02-09 | |
| 2025-06-30 | $6,202,081 | 13,931 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $5,489,132 | 11,322 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $3,412,882 | 8,475 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,524,841 | 7,579 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $12,668,095 | 27,027 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $11,652,864 | 27,877 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $9,061,847 | 22,271 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $6,416,498 | 18,452 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,241,475 | 17,736 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,530,642 | 8,032 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,171,336 | 7,519 | Shares | Sole | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||